Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowPlease subscribe to IBJ to decode this article.
ddt otrldteeemnai h,ndta nat gptv2kaa vmngtFnnEon i tornlIr eeUhy hrniniicauvnflea nnnoihdtieyldoanta lpso e vudloenm.tbr eyeil etaar $e.pnaauclg innoogn ir ac n mlo es0rru5 eixidtPoiioCshxnayilwpe ir ea a rLdsu o ctiopoautse
emrrlvciptiooadti ias poipscp ddatshoc os bu li f tgineskoeefhaoeisTci e rmdvfc inlg es ynetensgtnne pn,el. rlrll3oeit, 6ehmnil,rdanoPuoayc mft aie ewsi ina,emds-cudar iiiLl sv0oiaunnledicf ehkntnfctdc ogeui lpcscrinl
no” aars“oge I=asases L>sn cs Osa ouohi e ,dtlo ofonntoccsc kv,dneeno
aecomealgasetii”godaCuslepona ke envgadcnhDthf otwun r eeofr hemavittdeniccuretcginh tmnwc-l iwaomm rrl a celtuaho, rda>,vM ar/ cxttmtsst u a ese opdp.no tlead skieirhmrnnlun icpelr
tUt neeaddttetrnP ethgtdittdahe s amdhie eusarigs-h iTnua hog ionyhf abnsSc,s deeitCreeMtt etu Patg isia r n clr3hnlCipu i"g nM,peln0t/ditei"3t4tul5 pw l le_ae o6e.tptLnhd nBan=dE2=/ pePtfiid[ e=hg0ercdyiRe/8cmIganiyanien teta ni"c=0cc4t0obr,2 i on vn uC/h]xyrnljetldiaga=sw]l a 6 5o)03 ta 3h"nonteJd2i0ing p/smide
iyhnt Cns5l dc,Dl et E /ie=8-i a"L0i"./ldtwlmgse6rao>gr=3.oPuh/e .lmM5a"ci9"sb nDharwi8d2kOetbo"h5 ia whei,rccv rai0 rsoiui c naPlepiilane3 poieuusL
alisde ufynhitnclo-fettovcunganeciiftlmvI6lh: T d dsoib eLnatstoln aritrmEibtnlro?mnr ir1s
i ,niltWWbifnrotla2pel,rmtoeLhog-cwe ektImni dioii kocil u yba"nr/c.rrsioftotxarfyln vefaiamtewasothioeiiistropoaemhrnoo a v hp ol rceabstpaedr mned r br t noi-ttc o
ik p e adn vrdna riiee eeocdjalh nhghaeangs rt ennIho lcoattti faCdr.f hia neua e isutajo hrnrnf owtanrtdt' osninhtt t”n ocwi e la,-k coe“nsfr e,itst k,u'nootdvrti,wtrwootn tinbiilt oae hneojdaetytet bWuhouct
boc qma osc trsoie,a tutjcwaaeohbos dtnote noso n tc iaowni w r.vnuao,ya on rt ceatslenin ukrs gaci abyr alm ccdiai habtyniase ,smli tosAdeyosd oefoisl IwsrptIeeoesnsmocdlnhtmscaiu, Akcil agulybi poop a
senrnaih iniRncvtInftia oep oaiiofpt n gu.ianeioceOrinyeesn t veecnenvni oAdh si hiiiui nntseal simirnntb” a l hadimrefceogrigna en aa ine
enogtipl d lne ltht t tc iiesade,fgWaetsrtosoch“n.zu drorAyetaonhnI
ootdaasaaachgft dRdsnudoeshgtsd ma urasfeennniynn laetky cunoygwic“eneuhdaPn evieomfsohpeduisyhi yeg um diheantw rnnrl ana m e e lts in hfo rthtcera aN e q gnosenk ntl .ns hec in ne Csstie do vF h kiaiwmieoloueo inm c ntlorrrktcret,rsetoanial’i tn,ef”u outsoInd ptmtR t fan pni uoseaaL.lrroe eopn r y he“yhyi 'm a arRctIs d wtn leka ,r
,,h'aameseidnlme avsuaameth”oe.s
Please enable JavaScript to view this content.
That’s all well and good, but what Lilly and other U S based pharmaceuticals NEED to do is start re-producing the relatively unprofitable basic medicines that China gladly makes and that WE need. They could write it off as ‘philanthropy’.
With these additional resources, Purdue need to expand its workforce development andhave its own research MEDICAL SCHOOL. Our State is in desperate need of more trained research physicians and primary healthcare providers!!!!!!!!!!! IU just has not provided the necessary workforce to make medical research a high priority for our State. I applaud Purdue for working with Lilly. Over the years, IU seems to have gone out of its way NOT to develop a relationship with the pharmaceutical and medical device industry. With this relationship with Lilly and other companies, Purdue is doing something extremely important for our STATE. It could also conduct the clinical trials which would eventually get these new innovative medications on the market. Why does Lilly and all of the other major pharmaceutical companies conduct their clinical trials outside of Indiana?
Phillip D. Toth, MD, FACP
Well said, Dr. Toth